Generation of cytotoxic T lymphocytes to autologous human leukaemia cells by sensitisation to pooled allogeneic normal cells.

Cytotoxic activity of rheumatoid and normal lymphocytes against allogeneic and autologous synovial cells in vitro.

Sensitization of lymphocytes against pooled allogeneic cells. I. Generation of cytotoxicity against autologous human lymphoblastoid cell lines.

Lymphocyte transformation induced by autologous cells. IV. Human T-lymphocyte proliferation induced by autologous or allogeneic non-T lymphocytes.

Targeting of human cytotoxic T lymphocytes to MHC class II-expressing cells by staphylococcal enterotoxins.

In vitro generation of tumor-specific cytotoxic lymphocytes. Secondary allogeneic mixed tumor lymphocyte culture of normal murine spleen cells.

Differentiation of memory T cells to virus plaque-forming cells and cytotoxic T lymphocytes.

In vitro lymphocyte immunization to cultured human tumor cells: parameters for generation of cytotoxic lymphocytes.

Allogeneic tumor-specific cytotoxic T lymphocytes.

Induction of antigen-specific cytotoxic T lymphocytes by fusion cells generated from allogeneic plasmacytoid dendritic and tumor cells.

Induction of antigen-specific cytotoxic T lymphocytes by fusion cells generated from allogeneic plasmacytoid dendritic and tumor cells.

Herpes simplex virus-1-specific human cytotoxic T lymphocytes are induced in vitro by autologous virus-infected mononuclear cells.

Differential sensitivity of cytotoxic T lymphocytes and lymphokine-activated killer cells to inhibition by L-ornithine.

Autologous mixed lymphocyte culture reactions and generation of cytotoxic T cells.

High-fold expansion of human cytotoxic T-lymphocytes specific for autologous melanoma cells for use in immunotherapy.

Stimulation of autologous and allogeneic human T cells by B cells occurs through separate B-cell antigen systems.

Recognition and killing of autologous, primary glioblastoma tumor cells by human cytomegalovirus pp65-specific cytotoxic T cells.

A Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD4+ T-Cells to Recognition by Cytotoxic T-Lymphocytes.

Cytotoxic lymphocytes from normal donors. A functional marker of human non-T lymphocytes.

Localization of aggregated cell surface antigens of target cells bound to cytotoxic T lymphocytes.

Clonal deletion of postthymic T cells: veto cells kill precursor cytotoxic T lymphocytes.

A Well-Controlled Experimental System to Study Interactions of Cytotoxic T Lymphocytes with Tumor Cells.

Generation of lymphokine-activated killer cells by adherent LGL phenotype cells and non-adherent T lymphocytes.

Human bone marrow lymphocytes. Cytotoxic effector cells in the bone marrow of normal individuals.

S cells present endogenously synthesized cytosolic proteins to class I-restricted cytotoxic T lymphocytes.

Suggest Documents

Cytotoxic activity of rheumatoid and normal lymphocytes against allogeneic and autologous synovial cells in vitro.

Sensitization of lymphocytes against pooled allogeneic cells. I. Generation of cytotoxicity against autologous human lymphoblastoid cell lines.

Lymphocyte transformation induced by autologous cells. IV. Human T-lymphocyte proliferation induced by autologous or allogeneic non-T lymphocytes.

Targeting of human cytotoxic T lymphocytes to MHC class II-expressing cells by staphylococcal enterotoxins.

In vitro generation of tumor-specific cytotoxic lymphocytes. Secondary allogeneic mixed tumor lymphocyte culture of normal murine spleen cells.

Differentiation of memory T cells to virus plaque-forming cells and cytotoxic T lymphocytes.

In vitro lymphocyte immunization to cultured human tumor cells: parameters for generation of cytotoxic lymphocytes.

Allogeneic tumor-specific cytotoxic T lymphocytes.

Induction of antigen-specific cytotoxic T lymphocytes by fusion cells generated from allogeneic plasmacytoid dendritic and tumor cells.

Induction of antigen-specific cytotoxic T lymphocytes by fusion cells generated from allogeneic plasmacytoid dendritic and tumor cells.

Herpes simplex virus-1-specific human cytotoxic T lymphocytes are induced in vitro by autologous virus-infected mononuclear cells.

Differential sensitivity of cytotoxic T lymphocytes and lymphokine-activated killer cells to inhibition by L-ornithine.

Autologous mixed lymphocyte culture reactions and generation of cytotoxic T cells.

High-fold expansion of human cytotoxic T-lymphocytes specific for autologous melanoma cells for use in immunotherapy.

Stimulation of autologous and allogeneic human T cells by B cells occurs through separate B-cell antigen systems.

Recognition and killing of autologous, primary glioblastoma tumor cells by human cytomegalovirus pp65-specific cytotoxic T cells.

A Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD4+ T-Cells to Recognition by Cytotoxic T-Lymphocytes.

Cytotoxic lymphocytes from normal donors. A functional marker of human non-T lymphocytes.

Localization of aggregated cell surface antigens of target cells bound to cytotoxic T lymphocytes.

Clonal deletion of postthymic T cells: veto cells kill precursor cytotoxic T lymphocytes.

A Well-Controlled Experimental System to Study Interactions of Cytotoxic T Lymphocytes with Tumor Cells.

Generation of lymphokine-activated killer cells by adherent LGL phenotype cells and non-adherent T lymphocytes.

Human bone marrow lymphocytes. Cytotoxic effector cells in the bone marrow of normal individuals.

S cells present endogenously synthesized cytosolic proteins to class I-restricted cytotoxic T lymphocytes.

Generation of cytotoxic T lymphocytes to autologous human leukaemia cells by sensitisation to pooled allogeneic normal cells.

Recommend Documents

Follow Us